Medical Condition News

RSS

ISSP model can help payers realize oncology savings of $16.3M for every 10,000 Medicare beneficiaries

New Century Infusion Solutions, Inc. (NCIS), the first Oncology Benefit Management (OBM) company, is pleased to announce the publication of a white paper by the Lewin Group: “Medicare Cancer Care Coordination Using The Integrated Single Specialty Provider (ISSP) Model.” The report estimates that over a 10-year horizon, a payer could realize oncology savings of “$16.3 million for every 10,000 Medicare beneficiaries included in the ISSP arrangement.”

6 Mar 2010

New technologies have potential to help elderly people live independently

The population of the UK is ageing. Sixteen per cent of the UK population is 65 or older, and for the first time, there are more people over the age of 65 than there are under the age of 18. This raises a lot of questions on issues such as pension provision, health care and wellbeing. Ensuring that elderly people have access to medical and social support; the use of new technologies to make it easier for them to live independent lives; and helping the elderly to stay active within society.

6 Mar 2010

NAF to hold third annual Ataxia Investigators Meeting in Rosemont

The National Ataxia Foundation, in conjunction with the University of Chicago program in pathobiology and translational neuroscience, will hold its third annual Ataxia Investigators Meeting March 9-11, 2010, at the Hyatt Regency O'Hare, in Rosemont, Ill. A three-day meeting for patients, caregivers and families will follow at the same location.

6 Mar 2010

Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis

Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases.

6 Mar 2010

Increased risk of colorectal cancer associated with obesity may be restricted to tumors that have no MSI

The increased risk of colorectal cancer associated with obesity may be largely restricted to tumors that have no or low microsatellite instability (MSI), a common condition in most colorectal cancers, according to a new study published online March 8 in the Journal of the National Cancer Institute.

6 Mar 2010

Researchers assess clinical and cost impacts of PPI utilization in hospitalized patients

Proton pump inhibitors (PPIs) are the most effective agents for treating acid related gastrointestinal (GI) disorders. The utilization of intravenous (IV) formulations of PPIs has dramatically increased in health care institutions for inappropriate indications, route of administration and length of treatment. This is associated with an increased cost burden, increased risk of IV related infections, and utilization of hospital resources.

6 Mar 2010

Inpatient integrative medicine program can have significant impact on pain: Study

Non-traditional therapies relieve pain among a wide range of hospitalized patients as much as 50 percent, according to a first-of-a-kind study in the Journal of Patient Safety.

6 Mar 2010

Study reports increased incidence of colorectal cancer in China

The incidence of colorectal cancer (CRC) in China is lower than that in the west countries, but has increased in recent years and become a substantial cancer burden in China, particularly in the more developed areas.

6 Mar 2010

Thymosin beta 4 improves neurological functional outcome

REGENERX BIOPHARMACEUTICALS, INC. announced that a research team from the Henry Ford Hospital in Detroit, MI reported that Thymosin beta 4 (Tβ4), administered to rats one day after embolic stroke, improved neurological functional outcome compared to control animals.

6 Mar 2010

Adults with depression and diabetes face increase risk of dementia

Adults who have both diabetes and major depression are more than twice as likely to develop dementia, compared to adults with diabetes only, according to a study published in the recent Journal of General Internal Medicine.

6 Mar 2010

McGill, Enobia Pharma collaborate to develop treatments for serious genetic bone diseases

Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.

6 Mar 2010

Soluble Systems, SWAI launch TheraSkin to jumpstart healing in chronic and acute wounds

Soluble Systems, LLC and the Skin and Wound Allograft Institute, a wholly owned subsidiary of LifeNet Health, have signed a noteworthy agreement to launch TheraSkin™, a biologically active human skin allograft designed to jumpstart healing in chronic and acute wounds.

6 Mar 2010

Bunny's last days: When living will isn't enough

In this Kaiser Health News story, part of a special series on end-of-life care, reporter Susan Brink details certain circumstances related to end-of-life care and living wills.

5 Mar 2010

Hypertension: Regular nifedipine administration may lead to development of GERD

Nifedipine, a calcium-channel blocker, was shown to decrease lower esophageal sphincter pressure and increase esophageal acid exposure time, while atenolol, a b1 blocker, was shown to inhibit relaxation of the smooth muscle of the esophagus. However, the influence of these anti-hypertensive drugs on the segment of esophageal body contraction using high-resolution manometry was not fully investigated.

5 Mar 2010

New anti-tumour vaccine for mesothelioma shows promising results

A vaccine against mesothelioma, a cancer associated with exposure to asbestos, has shown early promise in its first clinical trial.

5 Mar 2010

Canadian federal government to renew Aboriginal Diabetes Initiative

The Canadian Diabetes Association and the National Aboriginal Diabetes Association applaud the federal government for its decision to renew the Aboriginal Diabetes Initiative (ADI) as presented in the budget announcement on March 4.

5 Mar 2010

Varicose veins may signal potential dangerous blood clots

March is DVT Awareness Month and Vein Clinics of America encourages people with varicose veins, particularly those that have become painful and inflamed, to visit a vein specialist.

5 Mar 2010

Study explores prognostic biomarkers in patients with lymph node-negative colorectal cancer

Tumor budding at the invasive tumor front of colorectal cancer is recognized as an independent prognostic factor significantly related to both lymph node and distant metastasis.

5 Mar 2010

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

Liver transplantation specialists recently convened to address U.S. guidelines for allocation of organs for patients with hepatocellular carcinoma (HCC, liver cancer). Representatives from more than 130 U.S. transplant centers were invited to the conference and participants included 180 leaders in liver transplantation (LT) from the 50 most active centers.

5 Mar 2010

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

InterMune, Inc. announced today that the U.S. Food and Drug Administration (FDA) has posted briefing documents for the March 9 Pulmonary-Allergy Drugs Advisory Committee (PADAC) meeting to review the New Drug Application (NDA) for pirfenidone, InterMune's investigational drug candidate for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function. The proposed trade name for pirfenidone is Esbriet®.

5 Mar 2010

Medical Condition News

ISSP model can help payers realize oncology savings of $16.3M for every 10,000 Medicare beneficiaries

New technologies have potential to help elderly people live independently

NAF to hold third annual Ataxia Investigators Meeting in Rosemont

Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis

Increased risk of colorectal cancer associated with obesity may be restricted to tumors that have no MSI

Researchers assess clinical and cost impacts of PPI utilization in hospitalized patients

Inpatient integrative medicine program can have significant impact on pain: Study

Study reports increased incidence of colorectal cancer in China

Thymosin beta 4 improves neurological functional outcome

Adults with depression and diabetes face increase risk of dementia

McGill, Enobia Pharma collaborate to develop treatments for serious genetic bone diseases

Soluble Systems, SWAI launch TheraSkin to jumpstart healing in chronic and acute wounds

Bunny's last days: When living will isn't enough

Hypertension: Regular nifedipine administration may lead to development of GERD

New anti-tumour vaccine for mesothelioma shows promising results

Canadian federal government to renew Aboriginal Diabetes Initiative

Varicose veins may signal potential dangerous blood clots

Study explores prognostic biomarkers in patients with lymph node-negative colorectal cancer

Liver transplantation specialists form guidelines for allocation of organs for patients with HCC

FDA's PADAC meeting to review pirfenidone NDA: InterMune posts briefing documents

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News